Second, the activation of CXCR2 results in increased expression of early growth response-1 (EGR-1) in esophageal cancer [126], which increases proliferation by elevating the expression of cyclin-dependent kinase 4 (CDK4). The gene discussed is CDK4; the disease is esophageal cancer.